A case report describing the spectrum of rheumatic heart disease in a patient with mitral restenosis.
Answers are grounded in this paper and cite their sources.
Illustrates rare RHD features in mitral restenosis; leaves open validation in larger cohorts before clinical application.
Rheumatic heart disease (RHD) is still highly prevalent in developing countries and accounts for sizeable cardiovascular morbidity. The mitral valve is the most commonly involved valve. Since its introduction by Inoue et al 1 in 1984 as an alternative to surgical mitral commissurotomy for treatment of rheumatic mitral stenosis (MS), percutaneous transvenous mitral commissurotomy (PTMC) has been successfully and safely performed in large series of patients at numerous centres. Excellent long-term results obtained after PTMC, like those of an open mitral valvotomy, are far superior to those after a closed mitral valvotomy (CMV).2 We presented a case of a patient with mitral restenosis after …
No takes yet. Share an insight, caveat, or question.
Hirapur et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: